1. Home
  2. LEE vs IPSC Comparison

LEE vs IPSC Comparison

Compare LEE & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lee Enterprises Incorporated

LEE

Lee Enterprises Incorporated

HOLD

Current Price

$8.54

Market Cap

160.1M

ML Signal

HOLD

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.32

Market Cap

189.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEE
IPSC
Founded
1890
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Newspapers/Magazines
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.1M
189.7M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
LEE
IPSC
Price
$8.54
$2.32
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$3.50
AVG Volume (30 Days)
110.1K
1.2M
Earning Date
05-07-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.30
EPS
N/A
N/A
Revenue
$543,955,000.00
$109,164,000.00
Revenue This Year
$5.48
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1556.76
52 Week Low
$3.34
$0.34
52 Week High
$10.88
$2.97

Technical Indicators

Market Signals
Indicator
LEE
IPSC
Relative Strength Index (RSI) 51.66 52.71
Support Level $8.35 $0.49
Resistance Level $9.74 $2.71
Average True Range (ATR) 0.74 0.26
MACD -0.24 -0.04
Stochastic Oscillator 30.22 27.22

Price Performance

Historical Comparison
LEE
IPSC

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

Share on Social Networks: